Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
7.635 USD | +0.59% | +2.15% | -23.23% |
Kurzporträt
Mitarbeiterzahl: 140
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Barbara Weber
CEO | Chief Executive Officer | 67 | 01.03.17 |
Daniella Beckman
DFI | Director of Finance/CFO | 45 | 01.10.16 |
Jannik Andersen
CTO | Chief Tech/Sci/R&D Officer | - | 01.01.19 |
Adam Crystal
CTO | Chief Tech/Sci/R&D Officer | 47 | 27.02.23 |
Samy Tadros
PRN | Corporate Officer/Principal | - | - |
John Ross
HRO | Human Resources Officer | - | 01.04.20 |
General Counsel | 54 | 01.08.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Alexis Borisy
CHM | Chairman | 52 | 01.01.17 |
Mace Rothenberg
BRD | Director/Board Member | 67 | 01.03.21 |
Barbara Weber
CEO | Chief Executive Officer | 67 | 01.03.17 |
Lesley Calhoun
BRD | Director/Board Member | 58 | 01.03.21 |
Malte Peters
BRD | Director/Board Member | 61 | 01.09.18 |
John Ketchum
BRD | Director/Board Member | - | 29.08.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 106 718 315 | 91 204 073 ( 85,46 %) | 0 | 85,46 % |
Unternehmenskontakt
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-23.23% | 810 Mio. | |
+23.98% | 48.09 Mrd. | |
+46.90% | 40.62 Mrd. | |
-3.01% | 40.43 Mrd. | |
-6.20% | 28.36 Mrd. | |
+9.47% | 24.89 Mrd. | |
-19.71% | 19.01 Mrd. | |
+29.48% | 12.09 Mrd. | |
+0.56% | 11.88 Mrd. | |
-0.96% | 11.8 Mrd. |
- Börse
- Aktien
- A3CWX9 Aktie
- Unternehmen Tango Therapeutics, Inc.